Faculty profile

nullMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

13 publications.

01

ACLY inhibition promotes tumour immunity and suppresses liver cancer

Gautam J, Wu J, Lally JSV, McNicol JD, Fayyazi R, Ahmadi E, Oniciu DC, Heaton S, Newton RS, Rehal S

Nature2025
02

Kidney Volume and Risk of Incident Kidney Outcomes

Wu J, Wang Y, Vlasschaert C, Lali R, Feiner J, Gaheer P, Yang S, Perrot N, Chong M, Paré G

Journal of the American Society of Nephrology202411 citationsFirst author
03

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

Biziotis O, Tsakiridis EE, Ali A, Ahmadi E, Wu J, Wang S, Mekhaeil B, Singh K, Menjolian G, Farrell T

Molecular Oncology202340 citations
04

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

Ali A, Mekhaeil B, Biziotis OD, Tsakiridis EE, Ahmadi E, Wu J, Wang S, Singh K, Menjolian G, Farrell T

Communications Biology202339 citationsOpen Access
05

Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice

Desjardins EM, Wu J, Lavoie DCT, Ahmadi E, Townsend LK, Morrow MR, Wang D, Tsakiridis EE, Batchuluun B, Fayyazi R

Cell Reports Medicine202339 citations
06

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome

Broadfield LA, Saigal A, Szamosi JC, Hammill JA, Bezverbnaya K, Wang D, Gautam J, Tsakiridis EE, Di Pastena F, McNicol J

Molecular Metabolism2022
07

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia

Morrow MR, Batchuluun B, Wu J, Ahmadi E, Leroux JM, Mohammadi-Shemirani P, Desjardins EM, Wang Z, Tsakiridis EE, Lavoie DCT

Cell Metabolism2022200 citations
08

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome

Broadfield LA, Saigal A, Szamosi JC, Hammill JA, Bezverbnaya K, Wang D, Gautam J, Tsakiridis EE, Di Pastena F, McNicol J

Molecular Metabolism202264 citations
09

The pesticide chlorpyrifos promotes obesity by inhibiting diet-induced thermogenesis in brown adipose tissue

Wang B, Tsakiridis EE, Zhang S, Llanos A, Desjardins EM, Yabut JM, Green AE, Day EA, Smith BK, Lally JSV

Nature Communications202172 citationsOpen Access
10

Bone cancer-induced pain is associated with glutamate signalling in peripheral sensory neurons

Zhu YF, Linher-Melville K, Wu J, Fazzari J, Miladinovic T, Ungard R, Zhu KL, Singh G

Molecular Pain202026 citations

Courses taught

3
  • Research Project in Computational Biology

    HTHSCI 3CP3 · last taught 2026

    Undergraduate
  • Introduction to Computational Biology

    HTHSCI 3CB3 · last taught 2025

    Undergraduate
  • Inquiry III: Advanced Inquiry in Health Sciences

    HTHSCI 3E03 · last taught 2023

    Undergraduate
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Liver Disease Diagnosis and Treatment Dear Professor Wu, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "ACLY inhibition promotes tumour immunity and suppresses liver cancer" (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction